Operating Results and Financial Position (annual)
For the fiscal year ended March 31, 2020, decreases were seen in revenue by 117,648 million yen (16.6%) year on year to 591,012 million yen, operating profit by 75,902 million yen (91.8%) year on year to 6,751million yen, profit before income taxes by 76,051 million yen (86.5% ) year on year to 11,864 million yen, and profit attributable to owners of the parent by 58,820 million yen (88.4%) year on year to 7,693 million yen.
[ Imaging Products Business ]
For the digital camera-interchangeable lens type, the Group made efforts to expand sales of mid- to high-end products for the professional and hobbyist segments by launching Z 50, a compact, lightweight and high-performance mirrorless camera, and D780, a high performance and multifunctional digital SLR camera, as well as by expanding the product line-up of interchangeable lenses for mirrorless cameras.
For the compact digital cameras, the Group focused on sales of high value-added products, with the launch of COOLPIX P950, which is equipped with an 83x optical zoom lens.
However, unit sales decreased due to the shrinking market, in addition to the decline in demand and the postponement of new product launches caused by the spread of COVID-19.
As a result, revenue for the Imaging Products Business decreased by 23.7% year on year to 225,894 million yen, and restructuring costs and impairment losses on non-current assets were recorded, resulting in the operating loss of 17,153 million yen (operating profit of 22,069 million yen was recorded in the previous fiscal year).
[ Precision Equipment Business ]
In the FPD lithography system field, unit sales fell overall despite steady sales of equipment that supports the Gen 10.5 plate size. Furthermore, sales of some equipment were postponed to the next fiscal year due to the spread of COVID-19, resulting in a significant decline in revenue and profits.
In the semiconductor lithography system field, the increase in unit sales of ArF immersion scanners and ArF scanners led to a rise in revenue and profits.
As a result, revenue for the Precision Equipment Business decreased by 12.7% year on year to 239,728 million yen, and operating profit decreased by 42.8% year on year to 46,774 million yen.
[ Healthcare Business ]
The bioscience field and the ophthalmic diagnosis field had been performing steadily toward an increase in sales of biological microscopes and ultra-wide field retinal imaging devices, respectively. However, growth slowed sharply in both fields due to the spread of COVID-19, resulting in reduced revenue.
As a result, revenue for the Healthcare Business decreased by 5.2% year on year to 62,024 million yen. Despite making efforts to minimize losses such as through cost reduction, operating loss grew to 2,455 million yen (as compared to an operating loss of 1,937 million yen in the previous fiscal year).
[ Industrial Metrology and Others ]
In the Industrial Metrology Business, revenue decreased due to sluggish market conditions mainly in China and the rest of Asia, as well as a cutback in investment caused by the spread of COVID-19. Although profitability increased as a result of efforts such as reducing costs, factors such as impairment of goodwill led to a decrease in profits.
In the Customized Products Business, revenue for solid-state lasers and optical components increased.
In the Glass Business, revenue decreased due to deteriorating market conditions caused by the spread of COVID-19, in spite of efforts to expand sales of photomask substrates for FPD.
As a result, revenue for the Industrial Metrology and Others decreased by 12.6% year on year to 63,366 million yen, and operating profit decreased by 54.1% year on year to 3,185 million yen.
The balance of total assets as of March 31, 2020 decreased 129,104 million yen from the end of the previous fiscal year to 1,005,881 million yen.
The balance of total equity as of March 31, 2020 decreased 74,966 million yen from the end of the previous fiscal year to 541,760 million yen.